Rocket Pharmaceuticals (DE:9IP1)
FRANKFURT:9IP1
Holding DE:9IP1?
Track your performance easily

Rocket Pharmaceuticals (9IP1) Balance Sheet

1 Followers

Rocket Pharmaceuticals Balance Sheet

Rocket Pharmaceuticals's total assets for Q3 2024 were $393.69M, a decrease of -11.81% from the previous quarter. DE:9IP1 total liabilities were $63.92M for the fiscal quarter, a 3.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 566.34M$ 551.81M$ 497.02M$ 590.82M$ 372.12M
Total Liabilities
$ 73.77M$ 62.12M$ 42.30M$ 87.31M$ 64.82M
Total Equity Gross Minority
$ 492.57M$ 489.69M$ 454.72M$ 503.52M$ 307.30M
Total Capitalization
$ 514.90M$ 510.04M$ 474.77M$ 593.14M$ 352.35M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Rocket Pharmaceuticals Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis